Drugs / LSD
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02451072 | Mar 2015 → Jan 2016 | — | Psychiatric University Hospital, Zurich | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LSD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02451072 ↗ |
| Action | Activate | “neural and experiential effects of lysergic acid diethylamide (LSD) are attributable to agonism of the serotonin-2A receptor” PMID 34313217 ↗ Jul 2021 |
| Route | Oral | “100µg per os” NCT02451072 ↗ |